Intra-Cellular Therapies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2011
Cash & Equivalents	149.52	150.37	93.77	61.45	107.64	54.95	37.79	48.64	47.16	61.33	Upgrade
Short-Term Investments	350.17	443.29	319.97	597.4	116.37	292.58	426.54	335.46	428.04	68.32	Upgrade
Cash & Cash Equivalents	499.69	593.66	413.73	658.85	224.01	347.53	464.33	384.1	475.2	129.65	Upgrade
Cash Growth	-15.83%	43.49%	-37.20%	194.12%	-35.54%	-25.15%	20.89%	-19.17%	266.54%	248.97%	Upgrade
Receivables	114.02	75.19	20.16	10.76	0	0	0	0.09	0.03	0.05	Upgrade
Inventory	50.27	23.92	7.95	7.06	0	0	0	0	0	0	Upgrade
Other Current Assets	3.82	45.19	25.44	14.24	6.31	7.91	4.88	4.01	8.03	1.29	Upgrade
Total Current Assets	667.8	737.96	467.28	690.9	230.32	355.44	469.22	388.2	483.26	130.99	Upgrade
Property, Plant & Equipment	14.58	16.74	22.56	26.32	20.51	1.16	1.14	0.63	0.78	0.05	Upgrade
Other Long-Term Assets	45.91	0.09	0.09	0.09	0.35	0.61	1.13	0.08	0.07	0.07	Upgrade
Total Long-Term Assets	60.5	16.82	22.64	26.41	20.86	1.77	2.27	0.7	0.85	0.13	Upgrade
Total Assets	728.3	754.78	489.92	717.31	251.19	357.21	471.49	388.9	484.1	131.11	Upgrade
Accounts Payable	11.45	10.4	8.69	5.5	7.43	13.96	6.17	3.75	1.63	2.05	Upgrade
Current Debt	3.61	4.57	6.73	5.54	3.19	0	0	0	0	0	Upgrade
Other Current Liabilities	108.48	68.27	37.93	25.81	25.61	22.34	8.04	6.78	4.63	8.5	Upgrade
Total Current Liabilities	123.55	83.24	53.36	36.85	36.22	36.3	14.21	10.53	6.26	10.56	Upgrade
Long-Term Debt	13.33	15.47	18.68	23.6	19.96	0	0	0	0	0	Upgrade
Other Long-Term Liabilities	0	0	0	0	0	3.19	2.84	2.87	1.6	0	Upgrade
Total Long-Term Liabilities	13.33	15.47	18.68	23.6	19.96	3.19	2.84	2.87	1.6	0	Upgrade
Total Liabilities	136.87	98.71	72.03	60.45	56.18	39.49	17.05	13.4	7.86	10.56	Upgrade
Total Debt	16.94	20.04	25.41	29.14	23.14	0	0	0	0	0	Upgrade
Debt Growth	-15.48%	-21.12%	-12.82%	25.92%	-	-	-	-	-	-	Upgrade
Retained Earnings	-1,617.16	-1,477.49	-1,221.23	-937.1	-710.1	-562.38	-407.25	-309.48	-193.05	-88.26	Upgrade
Comprehensive Income	0.1	-4.19	-0.36	0.48	0.13	-0.67	-0.8	-0.32	-0.59	-0.1	Upgrade
Shareholders' Equity	591.42	656.07	417.89	656.86	195.01	317.71	454.44	375.5	476.24	120.55	Upgrade
Net Cash / Debt	482.75	573.61	388.33	629.71	200.87	347.53	464.33	384.1	475.2	129.65	Upgrade
Net Cash / Debt Growth	-15.84%	47.71%	-38.33%	213.49%	-42.20%	-25.15%	20.89%	-19.17%	266.54%	248.97%	Upgrade
Net Cash Per Share	5.03	6.10	4.78	8.95	3.64	6.35	10.05	8.88	13.17	4.53	Upgrade
Working Capital	544.25	654.72	413.92	654.05	194.1	319.14	455.01	377.67	476.99	120.43	Upgrade
Book Value Per Share	6.17	6.98	5.14	9.34	3.53	5.81	9.84	8.68	13.20	4.21	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).